← Back to Search

Telephone Outreach for Colon Polyps (DESIRE Trial)

N/A
Waitlist Available
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months following outreach intervention
Awards & highlights

DESIRE Trial Summary

This trial is testing which method of outreach (letter, message, or call) is most effective in convincing people to switch to a 10-year colonoscopy schedule.

Eligible Conditions
  • Colon Polyps

DESIRE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months following outreach intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months following outreach intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of patients who respond with a 10-year surveillance interval change
Secondary outcome measures
Percentage of patients requesting a physician appointment

DESIRE Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Telephone OutreachActive Control1 Intervention
Group II: Secure MessageActive Control1 Intervention
Group III: Mailed LetterPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor
538 Previous Clinical Trials
24,113,184 Total Patients Enrolled
Jeffrey K Lee, MDStudy ChairKaiser Permanente
1 Previous Clinical Trials
740 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
De-implementation of Outdated Colonoscopy Surveillance Interval Recommendations Among Patients With Low-risk Adenomas
2022. "De-implementation of Outdated Colonoscopy Surveillance Interval Recommendations Among Patients With Low-risk Adenomas". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05389397.
~207 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top